UK markets closed
  • FTSE 100

    7,081.72
    +49.42 (+0.70%)
     
  • FTSE 250

    23,208.67
    +259.84 (+1.13%)
     
  • AIM

    1,257.61
    +6.50 (+0.52%)
     
  • GBP/EUR

    1.1690
    -0.0020 (-0.17%)
     
  • GBP/USD

    1.3878
    -0.0028 (-0.20%)
     
  • BTC-GBP

    28,674.53
    -1,173.52 (-3.93%)
     
  • CMC Crypto 200

    973.95
    +13.05 (+1.36%)
     
  • S&P 500

    4,396.57
    +1.31 (+0.03%)
     
  • DOW

    34,929.71
    -5.76 (-0.02%)
     
  • CRUDE OIL

    70.59
    -3.36 (-4.54%)
     
  • GOLD FUTURES

    1,818.20
    +1.00 (+0.06%)
     
  • NIKKEI 225

    27,781.02
    +497.43 (+1.82%)
     
  • HANG SENG

    26,235.80
    +274.77 (+1.06%)
     
  • DAX

    15,568.73
    +24.34 (+0.16%)
     
  • CAC 40

    6,675.90
    +63.14 (+0.95%)
     

Worldwide Medical Cartridges Industry to 2030 - Increasing Awareness About Diabetes Care Presents Opportunities

·9-min read

Dublin, July 19, 2021 (GLOBE NEWSWIRE) -- The "Medical Cartridges Market Research Report: By Material Type (Glass, Plastic), Size (Less than 3 ml, 3 ml to 5 ml, 6 ml to 10 ml, More than 10 ml), End User (Pharmaceutical and Biotech Companies, Biomedical Research Organizations) - Global Industry Revenue Estimation to 2030" report has been added to ResearchAndMarkets.com's offering.

With the increasing prevalence of acute and chronic diseases of all types, be it infection, autoimmune, metabolic, systemic, or cancer, the pharmaceutical industry is booming. As a result, the global medical cartridges market will grow from $920.8 million in 2020 to $1,691.1 million by 2030, at a 6.4% CAGR between 2021 and 2030. A lot of the drugs are given via the parenteral route, which is why the demand for cartridges, syringes, and vials is increasing.

Around 16 billion injections are given every year for contraceptive, blood transfusion, immunization, and curative purposes, according to the World Health Organization (WHO). In this regard, the rising demand for prefilled syringes is driving the medical cartridges market, as the drug inside such devices is essentially contained in a cartridge. Prefilled syringes help prevent needlestick injuries and minimize the wastage of drugs.

Due to the COVID-19 pandemic, the medical cartridges market is witnessing slow growth, as the lockdowns implemented around the world led to the shutdown of cartridge-manufacturing plants. Additionally, social distancing measures and movement restrictions meant that pharmaceutical representatives could not conduct face-to-face interactions with healthcare workers. Moreover, regulatory authorities have, for the moment, stopped approving pharmaceutical products, while many clinical trials have also been halted.

The glass bifurcation is expected to witness the faster growth in the medical cartridges market in the coming years, based on material type. Being inert, glass prevents reactions between the cartridge surface and the drug within. Additionally, glass stops volatile substances from penetrating the surface and mixing with the drug.

In the past, the end user segment of the medical cartridges market was dominated by pharmaceutical and biotech companies. With the growth of the pharma sector, drug, pen injector, and on-body injector manufacturers are increasingly using cartridges. In this regard, the rising adoption of pen injectors, especially by diabetics, is propelling the advance of this category, as are the technological advancements in drug delivery devices.

Presently, Europe generates the highest revenue in the medical cartridges market due to the increasing prevalence of diabetes, itself, in part, owing to the rise in the number of obese people. In the near future, the demand for cartridges will likely surge the most rapidly in Asia-Pacific (APAC). The region is witnessing a boom in its geriatric population, number of people suffering from diabetes, and healthcare expenditure.

The most-significant players in the global medical cartridges market are Stevanato Group, Gerresheimer AG, SCHOTT AG, Nipro Corporation, Thermo Fisher Scientific Inc., Baxter International Inc., Merck KGaA, Pierrel S.p.A., Transcoject GmbH, Novocol Pharma, and AptarGroup Inc.

Key Topics Covered:

Chapter 1. Research Background

Chapter 2. Research Methodology

Chapter 3. Executive Summary

Chapter 4. Introduction
4.1 Definition of Market Segments
4.1.1 By Material Type
4.1.1.1 Glass
4.1.1.2 Plastic
4.1.2 By End user
4.1.2.1 Pharmaceutical and biotech companies
4.1.2.2 Biomedical research organizations
4.1.2.3 Others
4.1.3 By Size
4.1.3.1 Less than 3 ml
4.1.3.2 3 ml to 5 ml
4.1.3.3 6 ml to 10 ml
4.1.3.4 More than 10 ml
4.2 Market Dynamics
4.2.1 Trends
4.2.1.1 Increasing use of cartridges in diagnostic applications
4.2.1.2 Rising production capacity of manufacturers
4.2.2 Drivers
4.2.2.1 Increasing demand for injectable pharmaceutical products
4.2.2.2 Growing pharmaceutical industry
4.2.2.3 Increasing aging population
4.2.2.4 Growing prevalence of acute and chronic diseases
4.2.2.5 Impact analysis of drivers on market forecast
4.2.3 Restraints
4.2.3.1 Adoption of alternative drug delivery methods
4.2.3.2 Impact analysis of restraints on market forecast
4.2.4 Opportunities
4.2.4.1 Increasing awareness about diabetes care
4.3 Impact of COVID-19
4.4 Porter's Five Forces Analysis
4.4.1 Bargaining Power of Buyers
4.4.2 Bargaining Power of Suppliers
4.4.3 Intensity of Rivalry
4.4.4 Threat of New Entrants
4.4.5 Threat of Substitutes

Chapter 5. Global Market Size and Forecast
5.1 By Material Type
5.2 By End User
5.3 By Size
5.4 By Region

Chapter 6. Europe Market Size and Forecast
6.1 By Material Type
6.2 By End User
6.3 By Size
6.4 By Country
6.4.1 Germany Market Size and Forecast
6.4.1.1 By material type
6.4.1.2 By end user
6.4.1.3 By size
6.4.2 France Market Size and Forecast
6.4.2.1 By material type
6.4.2.2 By end user
6.4.2.3 By size
6.4.3 U.K. Market Size and Forecast
6.4.3.1 By material type
6.4.3.2 By end user
6.4.3.3 By size
6.4.4 Italy Market Size and Forecast
6.4.4.1 By material type
6.4.4.2 By end user
6.4.4.3 By size
6.4.5 Spain Market Size and Forecast
6.4.5.1 By material type
6.4.5.2 By end user
6.4.5.3 By size
6.4.6 Netherlands Market Size and Forecast
6.4.6.1 By material type
6.4.6.2 By end user
6.4.6.3 By size

Chapter 7. North America Market Size and Forecast
7.1 By Material Type
7.2 By End User
7.3 By Size
7.4 By Country
7.4.1 U.S. Market Size and Forecast
7.4.1.1 By material type
7.4.1.2 By end user
7.4.1.3 By size
7.4.2 Canada Market Size and Forecast
7.4.2.1 By material type
7.4.2.2 By end user
7.4.2.3 By size

Chapter 8. APAC Market Size and Forecast
8.1 By Material Type
8.2 By End User
8.3 By Size
8.4 By Country
8.4.1 Japan Market Size and Forecast
8.4.1.1 By material type
8.4.1.2 By end user
8.4.1.3 By size
8.4.2 China Market Size and Forecast
8.4.2.1 By material type
8.4.2.2 By end user
8.4.2.3 By size
8.4.3 India Market Size and Forecast
8.4.3.1 By material type
8.4.3.2 By end user
8.4.3.3 By size
8.4.4 Australia Market Size and Forecast
8.4.4.1 By material type
8.4.4.2 By end user
8.4.4.3 By size

Chapter 9. LATAM Market Size and Forecast
9.1 By Material Type
9.2 By End User
9.3 By Size
9.4 By Country
9.4.1 Brazil Market Size and Forecast
9.4.1.1 By material type
9.4.1.2 By end user
9.4.1.3 By size
9.4.2 Mexico Market Size and Forecast
9.4.2.1 By material type
9.4.2.2 By end user
9.4.2.3 By size
9.4.3 Argentina Market Size and Forecast
9.4.3.1 By material type
9.4.3.2 By end user
9.4.3.3 By size

Chapter 10. MEA Market Size and Forecast
10.1 By Material Type
10.2 By End User
10.3 By Size
10.4 By Country
10.4.1 Saudi Arabia Market Size and Forecast
10.4.1.1 By material type
10.4.1.2 By end user
10.4.1.3 By size
10.4.2 U.A.E. Market Size and Forecast
10.4.2.1 By material type
10.4.2.2 By end user
10.4.2.3 By size
10.4.3 South Africa Market Size and Forecast
10.4.3.1 By material type
10.4.3.2 By end user
10.4.3.3 By size

Chapter 11. Competitive Landscape
11.1 Recent Strategic Developments of Players
11.1.1 Expansions
11.1.2 Partnerships and Collaborations
11.1.3 Other Developments
11.2 Market Share Analysis of Key Players

Chapter 12. Company Profiles
12.1 Stevanato Group
12.1.1 Business Overview
12.1.2 Product and Service Offerings
12.2 SCHOTT AG
12.2.1 Business Overview
12.2.2 Product and Service Offerings
12.2.3 Key Financial Summary
12.3 Gerresheimer AG
12.3.1 Business Overview
12.3.2 Product and Service Offerings
12.3.3 Key Financial Summary
12.4 Nipro Corporation
12.4.1 Business Overview
12.4.2 Product and Service Offerings
12.4.3 Key Financial Summary
12.5 Baxter International Inc.
12.5.1 Business Overview
12.5.2 Product and Service Offerings
12.5.3 Key Financial Summary
12.6 Thermo Fisher Scientific Inc.
12.6.1 Business Overview
12.6.2 Product and Service Offerings
12.6.3 Key Financial Summary
12.7 Merck KGaA
12.7.1 Business Overview
12.7.2 Product and Service Offerings
12.7.3 Key Financial Summary
12.8 Transcoject GmbH
12.8.1 Business Overview
12.8.2 Product and Service Offerings
12.9 Pierrel S.p.A
12.9.1 Business Overview
12.9.2 Product and Service Offerings
12.9.3 Key Financial Summary
12.10 AptarGroup Inc.
12.10.1 Business Overview
12.10.2 Product and Service Offerings
12.10.3 Key Financial Summary
12.11 Novocol Pharma
12.11.1 Business Overview
12.11.2 Product and Service Offerings

Chapter 13. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/a417ed

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting